COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Food and Drug Administration released updated enforcement policy related to face masks, barrier face coverings, face shields, surgical masks and respirators for the duration of the COVID-19 public health emergency.
The Centers for Disease Control and Prevention updated its guidance for health care personnel on preventing and controlling infections during the COVID-19 pandemic; managing health care personnel with SARS-CoV-2 infection or exposure; and preventing SARS-CoV-2 spread in nursing homes.
According to new Centers for Disease Control and Prevention research, hospitalization for COVID-19 for children and adolescents increased four-fold in August in states with low levels of vaccination, compared with states with high levels.
Team Strategies, Tools to Enhance Performance & Patient Safety to improve communication & teamwork in health care for colleagues, patients & families.
The Centers for Disease Control and Prevention alerted health care providers and the public to reports of severe illness associated with using products containing ivermectin to prevent or treat COVID-19.
Health care providers should stop using N95 respirators made by Shanghai Dasheng Health Products Manufacturing Co. Ltd., which are no longer authorized for emergency use, the Food and Drug Administration announced.
The Centers for Disease Control and Prevention released research highlighting two important trends emerging from the COVID-19 pandemic regarding vaccines’ current effectiveness.
The Food and Drug Administration today granted full approval for the Pfizer-BioNTech COVID-19 vaccine for individuals age 16 and over. The vaccine, which will now be marketed as Comirnaty, is the first COVID-19 vaccine to go beyond emergency use status in the United States.
The Centers for Medicare & Medicaid Services issued a Health Plan Management System memo to all Medicare Advantage Organizations and Medicare-Medicaid Plans to strongly encourage them to waive or relax plan prior authorization requirements and utilization management processes to facilitate the…
In evaluating whether to temporarily suspend survey activities if a hospital experiences a COVID-19 surge, the Centers for Medicare & Medicaid Services in June told AHA it will consider whether the hospital has notified the appropriate state public health agency and activated its emergency…